Biotechnology
New York, March 04, 2024 - PRISM MediaWire - Clinical-stage biotechnology firm Quoin Pharmaceuticals (Nasdaq: QNRX) has obtained FDA clearance to enroll subjects aged 14 years and above into its two ongoing clinical trials for QRX003. These trials are dedicated to assess...

4 March 2024

Artificial Intelligence:
New York, March 04, 2024 - PRISM MediaWire - United Airlines (UA) is set to introduce "Touchless ID" technology, replacing traditional boarding passes and IDs for passengers traveling through Chicago O'Hare and Los Angeles International airports. The program is slated fo...

4 March 2024

Biotechnology
New York, March 04, 2024 - PRISM MediaWire - NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) has obtained Institutional Review Board (IRB) approval to advance its Phase 1 clinical trial of DA-1726, targeting obesity treatment. Anticipated commencement of patient randomizati...

4 March 2024

Cannabis
New York, March 01, 2024 - PRISM MediaWire - Lexaria Bioscience (Nasdaq: LEXX) has made significant strides in advancing its CBD-based candidate for hypertension, marked by the recent clearance of its investigational new drug (IND) application by the FDA. With this regul...

1 March 2024

Electric Vehicles
New York, N.Y., February 29, 2024 - PRISM MediaWire - Indie Semiconductor, Inc. (INDI), renowned for its automotive software solutions and semiconductor expertise, has significantly propelled the advancement of vehicle electrification. In its recent report on Q4 earnings...

1 March 2024

Medical Devices
New York, N.Y., February 29, 2024 - PRISM MediaWire - Establishment Labs Holdings Inc. (ESTA) surged by 24% today, continuing its upward trajectory that began at the onset of the year. Included in the PRISM Women’s Health Index since its inauguration on January 4th, the ...

29 February 2024

Artificial Intelligence:
New York, N.Y., February 29, 2024 - PRISM MediaWire - LivePerson, Inc. (NASDAQ: LPSN) is currently experiencing significant challenges, evident in its impact on the PRISM NextGen Tech & AI Index where it stands as the largest detractor, causing a notable decline of a...

29 February 2024

Biotechnology
New York, N.Y., February 29, 2024 - PRISM MediaWire - Enveric Biosciences (NASDAQ: ENVB), a biotechnology firm specializing in the development of neuroplastogenic small-molecule therapeutics for mental health disorders, has announced the initiation of negotiations via th...

29 February 2024

Electric Vehicles
New York, N.Y., February 29, 2024 - PRISM MediaWire - Polestar Automotive Holding UK PLC (Nasdaq: PSNY) has recently announced the successful acquisition of $950 million through a three-year loan facility facilitated by a consortium of 12 prominent international banks, w...

29 February 2024

PRISM MarketView
New York, N.Y., February 29, 2024 - PRISM MediaWire - PRISM MarketView - Leading cannabinoid and psychedelic medicine biotechnology company, Incannex Healthcare (Nasdaq: IXHL), has achieved  positive topline results in its Phase 2 clinical trial of psilocybin in generali...

29 February 2024

1
2
3
4
5
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.